Brain Monitoring Systems Market is Projected to Witness a CAGR of 5.5% to Reach US$ 8.5 Billion by 2033 Says Future Market Insights, Inc.

Brain Tissue Oxygenation and Advanced Tracking Transforms the Brain Monitoring Systems Market, Records a CAGR of 5.5% from 2023 to 2033. EEG systems is likely to lead the product type category with a CAGR of 6.2% between 2023 and 2033.


NEWARK, Del, Jan. 19, 2023 (GLOBE NEWSWIRE) -- The Brain Monitoring Systems Market is anticipated to thrive at an average CAGR of 5.5% between 2023 and 2033. The market is likely to cross a market share of US$ 8.5 billion by 2033, while it is likely to be valued at US$ 5.0 billion in 2023.

- Brain monitoring systems are in high demand with the growing cases of brain paralysis and similar conditions. Furthermore, advanced brain monitoring systems track tiny changes in terms of consciousness.

- The expansion of neuroscience programs and their implementation in healthcare facilities and the advanced state-of-art technology processes EEG information to deliver better results is expected to fuel the demand for brain monitoring systems globally.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1259

- Brain monitoring systems are also applied to check how anesthesia has affected the mind and if the patient needs a higher or lower dose of it.

- Increased healthcare budget and rising awareness around brain health are also fueling the sales of brain monitoring systems.

- The advanced brain monitoring sensor with monitoring of the brain under anesthesia along with the EEG processing and data acquisition, expanding the brain monitoring systems market size.

- The vendors have also introduced EEG sensors that are available for adult and pediatric patients along with quick and simple applications. These sensors come with soft foam pads to improve patient comfort.

Key Points

The United States market leads the market in terms of market share. It is likely to cross a value of 2.7 billion by 2033. The regional market is expected to thrive at a CAGR of 6.4% between 2023 and 2033.

The China market is the leading space in terms of CAGR. It thrives at a CAGR of 7.6% during the forecast period. The market is likely to reach a value of US$ 905.9 million by 2033.

EEG systems are likely to thrive in the product category due to the early detection of abnormalities. It is expected to thrive at a CAGR of 6.2% during the forecast period.

The standalone segment tops the modality tally with a CAGR of 5.1% between 2023 and 2033, as it functions while detecting it more efficiently and effectively.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/1259

Competitive Landscape

The key players focus on creating customized brain monitoring solutions that work on different sects of the brain while monitoring the small details and developments in the brain and consciousness. The vendors create different BMS devices for different age groups and patients. The companies also merge, acquire, and partner with other companies to increase the supply chain and distribution channel.

The key players in the market include Neurosoft, Natus Medical Incorporated, Medtronic PLC, Integra Lifesciences, and Compumedics Neuroscan.

Recent Development:

  • Neurosoft has launched its neuromonitor which is a cerebral function monitor with a touchscreen interface. The monitoring device comes with clinical applications such as suspected cerebral function abnormality and hypoxic-ischemic encephalopathy (HIE).
  • Natus Medical Incorporated has introduced its natus brain monitor as a next-generation advanced amplifier for EEG and long-term monitoring and ICU studies.
  • Medtronic PLC adds its bispectral index (BIS) monitoring system that applied state-of-the-art technology to processes the direct measurement of patient’s brain vitals.

Key Segments:

Brain Monitoring Systems Market by Product:

  • fNIRS
  • EEG Systems
  • MEG Systems
  • MRI Systems
  • Others

Brain Monitoring Systems Market by Modality:

  • Portable/Handheld Brain Monitoring Systems
  • Standalone Brain Monitoring Systems

Brain Monitoring Systems Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Pediatric & Neonatal Intensive Care Units

Table of Content:

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1259

Have a Look at Related Research Reports of Healthcare Domain:

Hematopoietic Stem Cell Transplantation Market Size - The global hematopoietic stem cell transplantation market garnered a market value of US$ 7 Billion in 2023 and is expected to accumulate a market value of US$ 15 Billion by registering a CAGR of 8% in the forecast period 2023 to 2033

Edward’s Syndrome Treatment Market Growth - The global Edward’s syndrome treatment market is expected to garner a market value of US$ 4.9 Billion in 2023 and is expected to accumulate a market value of US$ 7.98 Billion by registering a CAGR of 5% in the forecast period 2023 to 2033

Filariasis Treatment Market Scope - The global filariasis treatment market is expected to reach US$ 10.96 Billion in 2023 and is projected to exhibit a CAGR of 10.1% from 2023 to 2033

Head and Neck Cancer (HNC) Therapeutics Market Outlook - The global Head and Neck Cancer (HNC) Therapeutics market is expected to surpass an impressive valuation of US$ 5.19 Billion in 2033 and is projected to exhibit a compound annual growth rate (CAGR) of 12.6% from 2023 to 2033

Eosinophilic Granulomatosis with Polyangiitis Treatment Market Trends - The global Eosinophilic Granulomatosis with Polyangiitis Treatment Market is currently valued at US$173.8 Million in 2023 and is anticipated to expand at a CAGR of 5.2%.

About Us :
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
LinkedInTwitterBlogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com